Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?

被引:30
作者
Tomlinson, D. R. [1 ]
Cherian, P. [1 ]
Betts, T. R. [1 ]
Bashir, Y. [1 ]
机构
[1] John Radcliffe Hosp, Dept Cardiac Rhythm Management, Oxford OX3 9DU, England
关键词
D O I
10.1136/emj.2007.051086
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To examine the efficacy of bolus dose intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained monomorphic ventricular tachycardia (VT). Design, setting and participants: Retrospective case series of consecutive emergency admissions with haemodynamically-tolerated sustained monomorphic VT administered bolus dose intravenous amiodarone 300 mg, according to current UK advanced life support practice guidelines. Main outcome measures: Pharmacological termination rates within 20 min and 1 h and incidence of hypotension requiring emergency direct current cardioversion (DCCV) during this period. Results: 41 patients ( 35 men) of mean (SD) age 68 ( 10) years, the majority (85%) with ischaemic heart disease and impaired left ventricular function ( mean ( SD) ejection fraction 0.31 (0.11)), were enrolled in the study. The median VT duration was 70 min ( range 15-6000), mean heart rate was 174 ( 34) bpm and systolic and diastolic blood pressures were 112 ( 22) and 73 ( 19) mm Hg, respectively. Pharmacological VT termination occurred within 20 min in 6/41 patients (15%; 95% Cl 7% to 29%) and within 1 h in 12/41 patients ( 29%; 95% Cl 18% to 45%). Haemodynamic deterioration requiring emergency DCCV occurred in 7/41 patients ( 17%; 95% Cl 8% to 32%). Conclusions: Although advocated by advanced life support guidelines, bolus dose intravenous amiodarone was relatively ineffective for acutely terminating haemodynamically-tolerated sustained monomorphic VT with a significant incidence of haemodynamic destabilisation requiring emergency DCCV. Previous studies in the identical clinical setting suggest that alternative antiarrhythmic agents, particularly intravenous procainamide and sotalol, may be superior. A prospective randomised trial is required to determine the optimal drug treatment for stable sustained monomorphic VT in the emergency setting.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 23 条
[1]  
[Anonymous], CIRCULATION
[2]   LACK OF EFFECTIVENESS OF LIDOCAINE FOR SUSTAINED, WIDE QRS COMPLEX TACHYCARDIA [J].
ARMENGOL, RE ;
GRAFF, J ;
BAERMAN, JM ;
SWIRYN, S .
ANNALS OF EMERGENCY MEDICINE, 1989, 18 (03) :254-257
[3]   REENTRY AS A CAUSE OF VENTRICULAR-TACHYCARDIA IN PATIENTS WITH CHRONIC ISCHEMIC HEART-DISEASE - ELECTROPHYSIOLOGIC AND ANATOMIC CORRELATION [J].
DEBAKKER, JMT ;
VANCAPELLE, FJL ;
JANSE, MJ ;
WILDE, AAM ;
CORONEL, R ;
BECKER, AE ;
DINGEMANS, KP ;
VANHEMEL, NM ;
HAUER, RNW .
CIRCULATION, 1988, 77 (03) :589-606
[4]   Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation [J].
Dorian, P ;
Cass, D ;
Schwartz, B ;
Cooper, R ;
Gelaznikas, R ;
Barr, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :884-890
[5]   Comparison of Procainamide and Lidocaine in terminating sustained monomorphic ventricular tachycardia [J].
Gorgels, APM ;
vandenDool, A ;
Hofs, A ;
Mulleneers, R ;
Smeets, JLRM ;
Vos, MA ;
Wellens, HJJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (01) :43-46
[6]   VENTRICULAR-TACHYCARDIA AS DEFAULT DIAGNOSIS IN BROAD COMPLEX TACHYCARDIA [J].
GRIFFITH, MJ ;
GARRATT, CJ ;
MOUNSEY, P ;
CAMM, AJ .
LANCET, 1994, 343 (8894) :386-388
[7]   DOUBLE-BLIND TRIAL OF LIGNOCAINE VERSUS SOTALOL FOR ACUTE TERMINATION OF SPONTANEOUS SUSTAINED VENTRICULAR-TACHYCARDIA [J].
HO, DSW ;
ZECCHIN, RP ;
RICHARDS, DAB ;
UTHER, JB ;
ROSS, DL .
LANCET, 1994, 344 (8914) :18-23
[8]  
*INT LIAIS COMM RE, 2005, RESUSCITATION, V67, P214
[9]   HEMODYNAMIC-EFFECTS OF INTRAVENOUS AMIODARONE [J].
KOSINSKI, EJ ;
ALBIN, JB ;
YOUNG, E ;
LEWIS, SM ;
LELAND, OS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 4 (03) :565-570
[10]   RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS AMIODARONE AND BRETYLIUM IN THE TREATMENT OF PATIENTS WITH RECURRENT, HEMODYNAMICALLY DESTABILIZING VENTRICULAR-TACHYCARDIA OR FIBRILLATION [J].
KOWEY, PR ;
LEVINE, JH ;
HERRE, JM ;
PACIFICO, A ;
LINDSAY, BD ;
PLUMB, VJ ;
JANOSIK, DL ;
KOPELMAN, HA ;
SCHEINMAN, MM .
CIRCULATION, 1995, 92 (11) :3255-3263